Back to Authors

Adams, Jon D

Mayo Clinic

Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota.

Citations 3

The Effect of Diabetes-Associated Variation in TCF7L2 on Postprandial Glucose Metabolism When Glucagon and Insulin Concentrations Are Matched

Metabolic Syndrome and Related Disorders | April 20, 2022 | Volume: 20 | Issue: 6 | Pages: 329-335

10.1089/met.2021.0136 | PMID 35442800

Insulin secretion and action and the response of endogenous glucose production to a lack of glucagon suppression in nondiabetic subjects

American Journal of Physiology-Endocrinology and Metabolism | October 18, 2021 | Volume: 321 | Issue: 5 | Pages: E728-E736

10.1152/ajpendo.00284.2021 | PMID 34658253

In prediabetes, anthropometric characteristics as well as insulin action do not alter the hepatic response to glucagon. The postprandial suppression or lack of suppression of glucagon secretion is an important factor governing postprandial glucose tolerance independent of insulin secretion.
Assessment of individual and standardized glucagon kinetics in healthy humans

American Journal of Physiology-Endocrinology and Metabolism | November 2, 2020 | Volume: 320 | Issue: 1 | Pages: E71-E77

10.1152/ajpendo.00488.2020 | PMID 33135460

State-of-the-art measurement of insulin secretion in humans is accomplished by deconvolution of peripheral C-peptide concentrations using population-derived parameters of C-peptide kinetics. In contrast, knowledge of the kinetic parameters of glucagon in humans is lacking so that measurement of glucagon secretion to date is largely qualitative. This series of experiments enabled measurement of glucagon kinetics in 51 subjects, and subsequently, stepwise linear regression was used to correlate these parameters with anthropometric characteristics. This enabled the development of a population-based model using anthropometric characteristics to predict the volume of distribution and the rate of clearance. This is a necessary first step in the development of a model to quantitate of glucagon secretion and action (and its contribution to glucose tolerance) in large populations.